Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 19 2020 - 5:00PM
Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a
medical aesthetics company, today announced that on February
13, 2020, the Compensation Committee of the Board of Directors
approved equity award grants under the Sientra
Inc. Inducement Plan to 92 new employees.
The new employees were granted restricted stock units
representing a total of 100,862 shares of common stock. The
restricted stock units will vest in time-based installments
beginning on the grant date. In each case, the vesting of shares is
contingent upon the recipient’s continued service with the Company
through each vesting date.
The grants were made as an inducement that was a material
component of each person’s compensation and subsequent acceptance
of employment with the Company or the Company’s miraDry subsidiary,
and were granted as employment inducement awards pursuant to NASDAQ
Listing Rule 5635(c)(4) approved by the Compensation Committee.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a
diversified global medical aesthetics company and a leading partner
to aesthetic physicians. The Company offers a suite of products
designed to make a difference in patients' lives by enhancing their
body image, growing their self-esteem, and restoring their
confidence. Sientra has developed a broad portfolio of products
with technologically differentiated characteristics, supported by
independent laboratory testing and strong clinical trial outcomes.
The Company’s Breast Products Segment includes its OPUS™ breast
implants, the first fifth generation breast implants approved by
the FDA for sale in the United States, its ground-breaking Allox2®
breast tissue expander with patented dual-port and integral drain
technology, and BIOCORNEUM® the #1 performing, preferred and
recommended scar gel of plastic surgeons[*]. The Company’s miraDry
Segment, comprises its miraDry® system, which is approved for sale
in over 40 international markets, and is the only non-invasive
FDA-cleared device for the permanent reduction of underarm sweat,
odor and hair of all colors.
[*] Data on file
Source: Sientra, Inc.
Investor Relations
805-679-8885
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Apr 2023 to Apr 2024